Eastern Cooperative Oncology Group
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Phase 2
Active, not recruiting
- Conditions
- LymphomaMantle Cell Lymphoma
- Interventions
- First Posted Date
- 2011-08-12
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 373
- Registration Number
- NCT01415752
- Locations
- 🇺🇸
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
🇺🇸Alaska Women's Cancer Care, Anchorage, Alaska, United States
🇺🇸Anchorage Oncology Centre, Anchorage, Alaska, United States
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 200
- Registration Number
- NCT01406782
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2011-07-11
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 32
- Registration Number
- NCT01390597
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2011-07-06
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 48
- Registration Number
- NCT01388569
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 220
- Registration Number
- NCT01385150
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Not Applicable
Completed
- Conditions
- Breast CancerStage IV Breast Cancer
- Interventions
- Procedure: palliative surgeryProcedure: therapeutic conventional surgeryRadiation: palliative radiation therapyRadiation: radiation therapy
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 390
- Registration Number
- NCT01242800
- Locations
- 🇺🇸
University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
🇺🇸Providence Cancer Center, Anchorage, Alaska, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2010-06-25
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 559
- Registration Number
- NCT01150643
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
Completed
- Conditions
- Leukemia
- First Posted Date
- 2010-06-16
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 225
- Registration Number
- NCT01145469
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer
Phase 2
Completed
- Conditions
- Precancerous ConditionHead and Neck Cancer
- Interventions
- Biological: cetuximabRadiation: intensity-modulated radiation therapy (IMRT)
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 90
- Registration Number
- NCT01084083
- Locations
- 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸California Cancer Care, Incorporated - Greenbrae, Greenbrae, California, United States
🇺🇸Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 136
- Registration Number
- NCT01079780
- Locations
- 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸Aurora Presbyterian Hospital, Aurora, Colorado, United States
🇺🇸Boulder Community Hospital, Boulder, Colorado, United States